Table 1 Patients characteristics
From: Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
| No. | |
|---|---|
| Patients | 65 |
| Mean age(years) | 64(range, 41-76) |
| Sex(male/female) | |
| Male | 61 |
| Female | 4 |
| Smoking history | 21 |
| Histological type | |
| Well differentiated | 21 |
| Moderately differentiated | 28 |
| Poorly differentiated | 16 |